Literature DB >> 10845905

Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin.

I Choi1, K Muta, A Wickrema, S B Krantz, J Nishimura, H Nawata.   

Abstract

Based on the hypothesis that interferon gamma (IFN-gamma) may have stimulating effects on survival of hematopoietic progenitor cells, we examined the effect of IFN-gamma on apoptosis of mature erythroid colony-forming cells (ECFCs) derived from human peripheral blood obtained from normal, healthy volunteers. When the cells were cultured in the presence of IFN-gamma, even without erythropoietin (EPO), the viability of the cells was maintained for at least 36 hours. When apoptosis of ECFCs was assessed by flow cytometric analysis', using annexin V, IFN-gamma reduced the extent of apoptosis of the cells, as well as EPO. DNA fragmentation of ECFCs was also reduced by IFN-gamma. In cells cultured with IFN-gamma alone, expression of Bcl-x was detected but the level of expression decreased gradually during incubation for 36 hours, and the expression level was lower than incubation with EPO. Fas expression and activation of downstream caspases were assessed by flow cytometric analysis or fluorometric protease assay. IFN-gamma induced Fas expression of the cells without the activation of caspase8 or caspase3 during 16 hours of incubation, while deprivation of EPO induced expression of Fas and the activation of both caspase8 and caspase3. We propose that IFN-gamma produces a stimulating signal for the survival of mature erythroid progenitor cells by reducing apoptosis through a mechanism other than modulating Fas and one related to the expression of Bcl-x. (Blood. 2000;95:3742-3749)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845905

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  A mechanism of ineffective erythropoiesis in β-thalassemia/Hb E disease.

Authors:  Pathrapol Lithanatudom; Amporn Leecharoenkiat; Tirawat Wannatung; Saovaros Svasti; Suthat Fucharoen; Duncan R Smith
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

2.  Association between Insulin-Like Growth Factor-I Levels and the Disease Progression and Anemia in Visceral Leishmaniasis.

Authors:  Flaviane Alves de Pinho; Célia Maria Vieira Vendrame; Bruna Leal Lima Maciel; Lucilene Dos Santos Silva; Samantha Ive Miyashiro; Selma Maria Bezerra Jerônimo; Hiro Goto
Journal:  Am J Trop Med Hyg       Date:  2019-04       Impact factor: 2.345

3.  Interferon gamma has dual potential in inhibiting or promoting survival and growth of hematopoietic progenitors: interactions with stromal cell-derived factor 1.

Authors:  Jin-Hee Hwang; Seong-Woo Kim; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Deog-Yeon Jo
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

4.  The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells.

Authors:  Kittiphong Paiboonsukwong; Ilseung Choi; Takamitsu Matsushima; Yasunobu Abe; Junji Nishimura; Pranee Winichagoon; Suthat Fucharoen; Hajime Nawata; Koichiro Muta
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

5.  Clinical severity of β-thalassaemia/Hb E disease is associated with differential activities of the calpain-calpastatin proteolytic system.

Authors:  Suriyan Sukati; Saovaros Svasti; Roberto Stifanese; Monica Averna; Nantika Panutdaporn; Tipparat Penglong; Edon Melloni; Suthat Fucharoen; Gerd Katzenmeier
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

6.  Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.

Authors:  Thomas Zobel; C-Thomas Bock; Uwe Kühl; Maria Rohde; Dirk Lassner; Heinz-Peter Schultheiss; Caroline Schmidt-Lucke
Journal:  Viruses       Date:  2019-03-06       Impact factor: 5.048

7.  Production of hemo- and immunoregulatory cytokines by erythroblast antigen+ and glycophorin A+ cells from human bone marrow.

Authors:  Sergey V Sennikov; Tatyana V Injelevskaya; Sergey V Krysov; Alexandr N Silkov; Igor B Kovinev; Natalya J Dyachkova; Anton N Zenkov; Mary I Loseva; Vladimir A Kozlov
Journal:  BMC Cell Biol       Date:  2004-10-18       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.